Post by Curida

👁️ The future of ophthalmics is becoming increasingly preservative-free. As patient expectations evolve and regulatory focus on long-term tolerability grows, pharmaceutical companies are rethinking how ophthalmic products are developed and delivered. For chronic eye conditions, preserving product sterility is essential—but so is preserving patient comfort. 💡 That's why preservative-free, unit-dose formats are gaining momentum across the ophthalmics market. The challenge? 🔬 Delivering preservative-free products at scale while maintaining the highest standards of sterility, quality, and compliance. In Curida's latest article, we explore how technologies such as Blow-Fill-Seal (BFS) are helping make this possible. 📖 Read the full article here: https://lnkd.in/euxjAkXk #Ophthalmics #PharmaManufacturing #SterileManufacturing #CDMO #Curida #PreservativeFree #BFS